Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Sobi files for E.U. approval of Xiapex for Peyronie's disease

June 26, 2014

Kadmon advances study of KD-020 in autosomal dominant polycystic kidney disease

June 23, 2014

ProMetic completes phase I trial of PBI-4050

June 20, 2014

Nymox reports nerve sparing and sexual preservation data on NX-1207

June 20, 2014

Nymox Pharmaceutical reports new safety study data for NX-1207

June 13, 2014

Complexa completes series B financing to support development of CXA-10

June 10, 2014

Roche patent divulges novel K(Ca)3.1 channel blockers

June 4, 2014

Dosing under way in phase IIa study of LPCN-1111 in hypogonadal men

May 30, 2014

U.S. investigators report development of HDAC inhibitors for AKI

May 29, 2014

FDA extends Zerenex PDUFA goal date

May 23, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...